• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs have been updated Aug. 1, 2021:

Effective Aug. 1, 2021:

  • Radicava
  • Otezla
  • Samsca

Effective Sept. 1, 2021:

  • Hemophilia Factor IX
  • Hemophilia Factor VIII
  • Human Fibrinogen Concentrate
  • Selective Serotonin Inverse Agonist (SSIA)
  • Topiramate ER
  • Weight Loss Agents (applies to Kansas Turnpike Authority (KTA) only)
  • Denosumab - Osteoporosis
  • Denosumab - Oncology
  • Acute Migraine Agents
  • Verquvo

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers